1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Bioproduction Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Bioproduction Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Bioproduction Market Regional Analysis
6.2 South & Central America Bioproduction Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Bioproduction Market Forecast Analysis
7. South & Central America Bioproduction Market Analysis – by Product
7.1 Biologics and Biosimilars
- 7.1.1 Overview
- 7.1.2 Biologics and Biosimilars: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Vaccines
- 7.2.1 Overview
- 7.2.2 Vaccines: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Cell and Gene Therapies
- 7.3.1 Overview
- 7.3.2 Cell and Gene Therapies: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Nucleic Acid Therapeutics
- 7.4.1 Overview
- 7.4.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. South & Central America Bioproduction Market Analysis – by Application
8.1 Rheumatoid Arthritis
- 8.1.1 Overview
- 8.1.2 Rheumatoid Arthritis: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Hematological Disorders
- 8.2.1 Overview
- 8.2.2 Hematological Disorders: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Cardiovascular Diseases
- 8.5.1 Overview
- 8.5.2 Cardiovascular Diseases: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. South & Central America Bioproduction Market Analysis – by Equipment
9.1 Upstream Equipment
- 9.1.1 Overview
- 9.1.2 Upstream Equipment: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Downstream Equipment
- 9.2.1 Overview
- 9.2.2 Downstream Equipment: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Bioreactors
- 9.3.1 Overview
- 9.3.2 Bioreactors: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Consumables and Accessories
- 9.4.1 Overview
- 9.4.2 Consumables and Accessories: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. South & Central America Bioproduction Market Analysis – by End User
10.1 Biopharmaceutical Companies
- 10.1.1 Overview
- 10.1.2 Biopharmaceutical Companies: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Contract Manufacturing Organizations
- 10.2.1 Overview
- 10.2.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. South & Central America Bioproduction Market – South and Central America Analysis
11.1 Overview
11.2 South and Central America
- 11.2.1 South & Central America Bioproduction Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 South & Central America Bioproduction Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 Brazil:
South & Central America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 Brazil: South & Central America Bioproduction Market Breakdown, by Product
- 11.2.1.1.2 Brazil: South & Central America Bioproduction Market Breakdown, by Application
- 11.2.1.1.3 Brazil: South & Central America Bioproduction Market Breakdown, by Equipment
- 11.2.1.1.4 Brazil: South & Central America Bioproduction Market Breakdown, by End User
- 11.2.1.2 Argentina:
South & Central America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Argentina: South & Central America Bioproduction Market Breakdown, by Product
- 11.2.1.2.2 Argentina: South & Central America Bioproduction Market Breakdown, by Application
- 11.2.1.2.3 Argentina: South & Central America Bioproduction Market Breakdown, by Equipment
- 11.2.1.2.4 Argentina: South & Central America Bioproduction Market Breakdown, by End User
- 11.2.1.3 Rest of South and Central America :
South & Central America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Rest of South and Central America : South & Central America Bioproduction Market Breakdown, by Product
- 11.2.1.3.2 Rest of South and Central America : South & Central America Bioproduction Market Breakdown, by Application
- 11.2.1.3.3 Rest of South and Central America : South & Central America Bioproduction Market Breakdown, by Equipment
- 11.2.1.3.4 Rest of South and Central America : South & Central America Bioproduction Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Lonza Group AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Danaher Corp
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Thermo Fisher Scientific Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Merck KGaA
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 F. Hoffmann-La Roche Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bio-Rad Laboratories Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations